Researchers have developed a novel two-stage AI model designed to predict pathological complete response (pCR) to neoadjuvant therapy in breast cancer patients. The model first infers the transcriptome from histopathology images across a large dataset, then uses this inferred expression along with clinical variables to predict treatment response. This approach achieved a pooled AUROC of 0.79 and demonstrated superior performance compared to traditional histopathological biomarkers, while also proving robust even with minimal biopsy tissue. AI
IMPACT This AI model could improve precision oncology by enabling more accurate prediction of treatment response from biopsy data.
RANK_REASON The cluster contains an academic paper detailing a new AI model and its evaluation. [lever_c_demoted from research: ic=1 ai=1.0]
- arXiv
- breast cancer
- Histopathology
- neoadjuvant therapy
- Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy
- transcriptome
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →